Over the last decades, there has been a growing scientific and societal concern arising for the possible effects of endocrine-disrupting compounds (EDCs) in humans and wildlife. As a result, many in vivo as well as in vitro studies have been developed to identify possible EDCs and determine potential hazards. Many of these studies focused on the interaction of these toxicants with estrogen receptors. However, many xenobiotics exert their endocrine-disrupting effects via other mechanisms of action, including those interfering with other steroid hormone receptors, steroidogenesis, and thyroid hormones (THs). Various regulatory agencies have expressed the need for extensive screening programs for potential EDCs, but such an approach would require an excessive amount of animals due to the high numbers of compounds to be tested. Thus, there is an urgent need for in vitro assays that are capable of rapidly identifying various endocrine-disrupting properties, preferably using a high-throughput system. At present, a wide array of in vitro screening assays using e.g. genetically modified yeast or immortal tumor cell lines have been developed to detect interactions with various sex steroid hormone receptors. In this respect, the development of in vitro screening assays for TH interactions clearly lags behind, in spite of the fact that changes in TH homeostasis can have deleterious health effects on development or normal physiological functions in vertebrate species. In the present issue of Toxicological Sciences, Hornung et al. (2010) describe the development and validation of an in vitro/ex vivo assay using thyroid glands of Xenopus laevis tadpoles, which offers good future perspectives of more reliable and accurate testing of thyroid toxicants.
Multiple points of interference have been identified for THs, including the hypothalamus-pituitary-thyroid (HPT) axis, thyroid hormone receptors (TR), transport proteins, and enzymes involved with synthesis and metabolism of TH (Zoeller et al., 2007a) . In addition, several feedback mechanisms are present in the body, through that may influence TH homeostasis. An important point of interference is the HPT axis in which the thyroid-stimulating hormone (TSH) and the thyrotropin-releasing hormone released by, respectively, the pituitary and the hypothalamus play a major role. All these interactions can result in a wide array of pleiotropic responses ranging from direct effects on the thyroid and the pituitary to more complicated secondary effects on the central nervous system and the brain. To complicate things further, sensitivities and differences in maintaining TH homeostasis vary between different classes of vertebrates and individuals (Fort et al., 2007) . In relation to the in vitro assay developed by Hornung et al., it should be noted that the function and follicular structure of the amphibian thyroid resembles that of mammalians but e.g. binding of thyroxine (T4) and triiodothyronine (T3) to transport proteins differs. When considering all these points of possible interference (DeVito et al., 1999; Schmutzler et al., 2007) , it seems therefore unlikely that the ''ultimate'' single in vitro assay for determining thyroid (hormone) toxicity will be developed.
As a result of these interactions and feedback mechanisms (see Fig. 1 ), there is little doubt that in vivo experiments still provide the highest certainty for detecting potential thyroid toxicity of chemicals. Especially (neuro)developmental and reproductive studies with rodents, such as the OECD TG 421 and 422 guidelines, allow sufficient possibilities to study thyroid toxicity. Functional end points like TH, TSH, or histopathological changes of the thyroid can easily be included and measured in these studies, in spite of the fact that other end points are usually the primary focus of these studies (Zoeller et al., 2007b) . From an in vivo point of view, the more recent development of the amphibian metamorphosis bioassay with e.g. X. laevis tadpoles (OECD DRP 46) is considered to be one of the most specific tests for evaluating disruptions of the HPT axis in a vertebrate species (Fort et al., 2007; U.S. EPA, 2009) . The above-mentioned in vivo studies clearly incorporate multiple functional mechanisms that might be influenced by potential thyroid toxicants and could be used as the ultimate proof. However, this should not prevent the scientific community from developing novel in vitro assays, which reduce the number of animals and costs and at least provide some information about thyroid toxicity in the early testing phase. At present, only a very limited number of in vitro assays are available for such a quick identification of TH-disrupting compounds. One of these bioassays is the pituitary GH3 cell line, which reasonably identifies chemicals that can act either as agonist or antagonist on the TR (DeVito et al., 1999; Hohenwarter et al., 1996) . Growth of this cell line is TH dependent and offers clear possibilities for high-throughput screening, but its use is limited to interactions with TR only. In addition, several thyroid cell lines and primary thyrocytes may be used for similar purposes but lack follicular organization of the thyroid gland. Furthermore, several extracellular assays are available that measure specific binding of compounds to TH transport proteins, like thyroid-binding globulin and transthyretin (Marchesini et al., 2008) . Enzymatic assays are also available to determine interactions with deiodinases and thyroid peroxidases (DeVito et al., 1999) . Although these in vitro assays are clearly time and cost-effective in relation to in vivo studies, the major drawback is the focus on a single end point and lack of information on the functioning of the whole thyroid. Clearly, the development of an in vitro/ex vivo assay with a thyroid gland that has kept its functional integrity and natural response to TSH would be a significant step forward for the screening methodology of potential thyroid toxicants. This is where the novel amphibian thyroid assay developed by Hornung et al. (2010) has filled an important gap in the testing strategies for EDCs. In their study, the authors used explant cultures of the thyroid gland of X. laevis tadpoles at stages 58 and 59, which is characterized by a rapid growth of the hind leg and is under control of TH. A significant feedback mechanism that stimulates the thyroid to produce T4 is TSH produced by the pituitary. The authors established, either using cocultures with pituitary tissue of the same animal or via THE USE OF CULTURED AMPHIBIAN THYROID GLANDS 5 bovine TSH, that the thyroid retained its normal endocrine response to T4 induction. This was an important validation step that showed that thyroid function was intact with regard to signaling from the pituitary with TSH. As multiple steps are involved in the synthesis of T4 in the thyroid, including iodine uptake and thyroid peroxidases, several experiments with specific inhibitors were performed for further validation of the assay. By using 6-propylthiouracil and perchlorate as inhibitors of, respectively, thyroperoxidases or iodine uptake, it was shown that these functional activities were still active in the tadpole thyroids. Thus, this confirmed that these explant thyroid cultures had retained their normal endocrine activities with respect to induction or inhibition of T4 synthesis. Additional histopathological analyses showed that the thyroid had kept its natural follicular organization, which is different from assays with primary thyrocytes or immortal thyroid cell lines.
In their conclusions, the authors state that this bioassay is well suitable to identify thyroid toxicants working directly on this specific part of the HPT axis. However, they also arrive to the conclusion that this novel in vitro assay is not easy to use as a high-throughput screening system. Therefore, it should rather be used as a simple yes or no test regarding the capacity of a compound to alter T4 synthesis in the thyroid. In addition, these explant cultures are also very useful to study specific mechanism of action of thyroid toxicants to established whether disruptive effects are caused by the TSH-stimulated pathway, iodide uptake, or role of thyroperoxidases. By putting these results in this perspective, the authors provide the reader with the reality: A fully functional in vitro and high-throughput thyroid screening assay is not yet available. However, this novel thyroid assay is another important step forward in studying potential toxicants because it includes a thyroid that still has essential and functional mechanisms for T4 synthesis. On the other hand, we have to realize that this assay still relies on the use of animals, although its design certainly cuts down time and costs otherwise been spent on classical in vivo amphibian metamorphosis assay. For high-throughput screening, several other in vitro assays for thyroid peroxidase enzymes or iodide uptake are more suitable (Cianchetta et al., 2010; DeVito et al., 1999) but do not allow an integrated picture of possible thyroid toxicity of a compound as this novel assay does.
As with any other in vitro assay for hormonal EDCs, the possibility of false-negative results is realistic due to multiple extra-thyroid mechanisms like metabolism or protein transport of TH, which could also be responsible for an adverse THdependent pleiotropic response. However, this novel amphibian thyroid assay appears at least complete with respect to the modulation of T4 synthesis and the thyroid response on TSH. Above and beyond its use for environmental risk assessment, the novel assay can also be used for hazard identification for humans when identifying potential thyroid toxicants because the amphibian HPT axis bears many similarities with that of mammals. Interestingly, the authors also performed a number of coculture experiments using paired thyroids and pituitary from the same animal for validation purposes. Results showed that in these cocultures, the pituitary-thyroid (PT) axis remained fully functional with respect to T4 synthesis and TSH signaling. Consequently, it might be suggested that the use of these cocultures may be the next step to achieve a more endocrinological relevant in vitro approach to study interactions of EDCs on the PT axis.
